top of page
FISHER WALLACE LABORATORIES
Login to favorite a company
Medical Devices for Mood and Sleep
Most Recent Valuation:
100280000
Legal Name:
Founded:
State of HQ:
Fisher Wallace Laboratories, Inc.
8/23/2019
Company Description
Employees:
[]
Funding Summary
Number of funding rounds
#
Total amount raised
$4,232,863
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
Fisher Wallace Laboratories Common Stock 2 | 08/11/2023 | $519,405.23 | closed | Common Stock | $192 | $100,280,000 | 10.67 | |
closed | $491 | $100,280,000 | ||||||
Fisher Wallace Common Stock 4 | 02/19/2023 | $1,006,284.57 | closed | Common Stock | $493 | $81,600,000 | 8.81 | |
Fisher Wallace Laboratories Inc. Common Stock 3 | 09/22/2022 | $357,719.00 | closed | Common Stock | $19,382 | $81,200,000 | 8.81 | |
Fisher Wallace Laboratories Common Stock 2 | 05/28/2022 | $1,279,724.00 | closed | Common Stock | $499 | $80,000,000 | 8.76 | |
Fisher Wallace Stock 1 | 03/13/2020 | $1,069,730.00 | closed | Common Stock | $250 | $15,000,000 | 2.5 | |
Fisher Wallace Laboratories 1 | closed |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|
Loading...
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page